- Home
- DBCA vs MTLS Comparison
DBCA vs MTLS Comparison
Compare DBCA & MTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DBCA | MTLS |
|---|---|---|
| Founded | 2025 | 1990 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | Blank Checks | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.3M | 387.8M |
| IPO Year | 2025 | 2014 |
Fundamental Metrics
Financial Performance| Metric | DBCA | MTLS |
|---|---|---|
| Price | $10.02 | $6.87 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 30.1K | ★ 54.1K |
| Earning Date | N/A | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.38 |
| Revenue Next Year | N/A | $6.45 |
| P/E Ratio | ★ N/A | $61.39 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.83 | $4.78 |
| 52 Week High | $10.07 | $7.50 |
Technical Indicators
Market Signals| Indicator | DBCA | MTLS |
|---|---|---|
| Relative Strength Index (RSI) | 66.31 | 55.95 |
| Support Level | $9.83 | $6.36 |
| Resistance Level | $10.05 | $6.94 |
| Average True Range (ATR) | 0.01 | 0.17 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 100.00 | 81.69 |
Price Performance
Historical ComparisonAbout DBCA D. Boral Acquisition I Corp. Class A Ordinary Shares
D Boral Acquisition I Corp is a blank check company. It is formed as a BVI business company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About MTLS Materialise NV
Materialise NV is a provider of 3D-printed medical devices and software and a pioneer in additive manufacturing software and services. The company operates through three principal segments: Materialise Software, Materialise Medical, and Materialise Manufacturing, with the Materialise Medical segment generating maximum revenue. The Materialise Medical segment develops and delivers medical software solutions, medical devices, and related products and services; the Materialise Software segment develops and delivers additive manufacturing software solutions and related services; and the Materialise Manufacturing segment delivers 3D-printed products and related services. The company generates maximum revenue from the United States of America.